Indeterminate Colitis clinical trials at University of California Health
2 in progress, 0 open to eligible people
5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Sorry, in progress, not accepting new patients
TARGET-IBD is a 5-year, longitudinal, observational study of adult and pediatric patients (age 2 and above) being managed for Inflammatory Bowel Disease (IBD) in usual clinical practice. TARGET-IBD will create a research registry of patients with IBD within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
at UC Davis
Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the long-term safety and clinical status of pediatric patients with Inflammatory Bowel Disease (IBD). Particular attention will be directed to recording safety outcomes reported in association with infliximab and other prescribed IBD therapies. In addition, information on disease status and quality of life will be collected.
at UCSF
Our lead scientists for Indeterminate Colitis research studies include Mel Heyman.
Last updated: